|
1
|
Lloyd RV, Buehler D and Khanafshar E:
Papillary thyroid carcinoma variants. Head Neck Pathol. 5:51–56.
2011. View Article : Google Scholar
|
|
2
|
Slough CM and Randolph GW: Workup of
well-differentiated thyroid carcinoma. Cancer Control. 13:99–105.
2006.PubMed/NCBI
|
|
3
|
LiVolsi VA: Papillary thyroid carcinoma:
an update. Mod Pathol. 24(Suppl 2): S1–S9. 2011. View Article : Google Scholar
|
|
4
|
Bai Y, Kakudo K, Li Y, Liu Z, Ozaki T, Ito
Y, Kihara M and Miyauchi A: Subclassification of non-solid-type
papillary thyroid carcinoma identification of high-risk group in
common type. Cancer Sci. 99:1908–1915. 2008.PubMed/NCBI
|
|
5
|
Bai Y, Kakudo K, Nakamura M, Ozaki T, Li
Y, Liu Z, Mori I, Miyauchi A and Zhou G: Loss of cellular
polarity/cohesiveness in the invasive front of papillary thyroid
carcinoma and periostin expression. Cancer Lett. 281:188–195. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y,
Klaus M, Reed JC and Zhang X: Retinoic acid receptor β mediates the
growth-inhibitory effect of retinoic acid by promoting apoptosis in
human breast cancer cells. Mol Cell Biol. 16:1138–1149. 1996.
|
|
7
|
DeGroot LJ, Kaplan EL, McCormick M and
Straus FH: Natural history, treatment, and course of papillary
thyroid carcinoma. J Clin Endocrinol Metab. 71:414–424. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hay ID: Papillary thyroid carcinoma.
Endocrinol Metab Clin North Am. 19:545–576. 1990.
|
|
9
|
Brtko J: Retinoids, rexinoids and their
cognate nuclear receptors: character and their role in
chemoprevention of selected malignant diseases. Biomed Pap Med Fac
Univ Palacky Olomouc Czech Repub. 151:187–194. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brtko J and Dvorak Z: Role of retinoids,
rexinoids and thyroid hormone in the expression of cytochrome p450
enzymes. Curr Drug Metab. 12:71–88. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brtko J and Thalhamer J: Renaissance of
the biologically active vitamin A derivatives: established and
novel directed therapies for cancer and chemoprevention. Curr Pharm
Des. 9:2067–2077. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schmutzler C, Brtko J, Bienert K and
Köhrle J: Effects of retinoids and role of retinoic acid receptors
in human thyroid carcinomas and cell lines derived therefrom. Exp
Clin Endocrinol Diabetes. 104(Suppl 4): S16–S19. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Z, Zhou G, Nakamura M, Bai Y, Li Y,
Ozaki T, Mori I, Miyauchi A and Kakudo K: Retinoid X receptor γ
up-regulation is correlated with dedifferentiation of tumor cells
and lymph node metastasis in papillary thyroid carcinoma. Pathol
Int. 61:109–115. 2011.
|
|
14
|
Tang W, Nakamura Y, Zuo H, Yasuoka H, Yang
Q, Wang X, Nakamura M, Mori I, Miyauchi A and Kakudo K:
Differentiation, proliferation and retinoid receptor status of
papillary carcinoma of the thyroid. Pathol Int. 53:204–213. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Casula S and Bianco AC: Thyroid hormone
deiodinases and cancer. Front Endocrinol (Lausanne). 3:742012.
|
|
16
|
Greene FL and Sobin LH: The TNM system:
our language for cancer care. J Surg Oncol. 80:119–120. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kimura Y, Suzuki T, Kaneko C, Darnel AD,
Moriya T, Suzuki S, Handa M, Ebina M, Nukiwa T and Sasano H:
Retinoid receptors in the developing human lung. Clin Sci (Lond).
103:613–621. 2002.PubMed/NCBI
|
|
18
|
Brtko J, Sejnová D, Ondková S and Macejová
D: Malignant Triton tumour exhibits a complete expression pattern
of nuclear retinoid and rexinoid receptor subtypes. Gen Physiol
Biophys. 28:425–427. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Franceschi S, Boyle P, Maisonneuve P, La
Vecchia C, Burt AD, Kerr DJ and MacFarlane GJ: The epidemiology of
thyroid carcinoma. Crit Rev Oncog. 4:25–52. 1993.
|
|
20
|
Clark DP and Faquin WC: Thyroid
Cytopathology. Springer Science and Business Media Inc.; New York,
NY: 2011
|
|
21
|
Amico P, Lanzafame S, Li Destri G, Greco
P, Caltabiano R, Vecchio GM and Magro G: Warthin tumor-like
papillary thyroid carcinoma with a minor dedifferentiated
component: report of a case with clinicopathologic considerations.
Case Report Med. 2010:4952812010.
|
|
22
|
Paker I, Kokenek TD, Yilmazer D, Seker GE
and Alper M: Oncocytic variant of papillary thyroid carcinoma with
lymphocytic stroma (Warthin-like variant): report of a case with
fine needle variant cytology and review of the literature.
Cytopathology. 23:408–410. 2012. View Article : Google Scholar
|
|
23
|
Hoftijzer HC, Liu YY, Morreau H, van Wezel
T, Pereira AM, Corssmit EP, Romijn JA and Smit JW: Retinoic acid
receptor and retinoid X receptor subtype expression for the
differential diagnosis of thyroid neoplasms. Eur J Endocrinol.
160:631–638. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haugen BR, Larson LL, Pugazhenthi U, Hays
WR, Klopper JP, Kramer CA and Sharma V: Retinoic acid and retinoid
X receptors are differentially expressed in thyroid cancer and
thyroid carcinoma cell lines and predict response to treatment with
retinoids. J Clin Endocrinol Metab. 89:272–280. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brtko J, Macejova D and Galbavy S: Thyroid
non-Hodgkin's lymphoma expression pattern of nuclear retinoid and
rexinoid receptor subtypes. Gen Physiol Biophys. 29:411–413.
2010.
|
|
26
|
Papi A, Rocchi P, Ferreri AM and Orlandi
M: RXRγ and PPARγ ligands in combination to inhibit proliferation
and invasiveness in colon cancer cells. Cancer Lett. 297:65–74.
2010.
|
|
27
|
Yen WC, Prudente RY, Corpuz MR,
Negro-Vilar A and Lamph WW: A selective retinoid X receptor agonist
bexarotene (LGD1069, targretin) inhibits angiogenesis and
metastasis in solid tumours. Br J Cancer. 94:654–660.
2006.PubMed/NCBI
|
|
28
|
Macejova D, Radikova Z, Macho L, Liska J
and Brtko J: MNU-induced carcinogenesis of rat mammary gland:
effect of thyroid hormone on expression of retinoic acid receptors
in tumours of mammary gland. Mol Cell Endocrinol. 244:47–56. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Romitti M, Wajner SM, Zennig N, Goemann
IM, Bueno AL, Meyer EL and Maia AL: Increased type 3 deiodinase
expression in papillary thyroid carcinoma. Thyroid. 22:897–904.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weinert LS, Ceolin L, Romitti M, Camargo
EG and Maia AL: Is there a role for inherited TRβ mutation in human
carcinogenesis? Arq Bras Endocrinol Metabol. 56:67–71.
2012.PubMed/NCBI
|
|
31
|
Macejova D, Ondkova S and Brtko J: Vitamin
D3 affects expression of thyroid hormone receptor alpha and
deiodinase activity in liver of MNU-treated Sprague-Dawley rats.
Gen Physiol Biophys. 28:363–370. 2009. View Article : Google Scholar : PubMed/NCBI
|
